Thursday, July 19, 2007

Certification trainings now offered for PNW health care providers in use of cranial electrotherapy stimulation treatment for anxiety & depression

Allevia Health, Inc. is pleased to announce it is offering trainings in the use of Alpha-Stim(r) cranial electrotherapy stimulation (CES) with the opportunity for certification in proficiency. The first trainings will be held August 4 in Seattle and August 18 in Portland. Health care providers will learn about cranial electrotherapy stimulation for the treatment of anxiety, depression, and insomnia. The Alpha-Stim device has been FDA-approved for use in treating these conditions.

Applied simply through ear clips, the Alpha-Stim delivers a mild, often subsensory (.5 hz) pulse to the earlobes. Anti-anxiety effects are typically felt immediately and last for one or two days after a treatment. Relief from depression typically requires 3 or more weeks of treatments. The device increases levels of endorphins and serotonin in the brain as well as normalizing brain wave patterns.

CES can be used with patients by any health care provider who is licensed to diagnose and treat anxiety, depression, or insomnia. This includes physicians, nurse practitioners, dentists, psychologists and licensed social workers.

The training will include review of the relevant research and clinical results and demonstration of the Alpha-Stim devices. The training also provides an excellent opportunity to ask questions and to talk with other providers who have experience with CES. While certification is not required to use the Alpha-Stim in one’s practice, many practitioners find that the in-depth training is helpful in incorporating the Alpha-Stim into their practice.

Providers interested in participating, and patients interested in more information on CES, may call Allevia Health, Inc. at 800-684-9343 or email info@alleviahealth.com.

Wednesday, July 11, 2007

Online discussion group for health care providers

Allevia Health, Inc. has launched an online discussion group for physicians, psychologists, social workers and other health care practitioners who are using Alpha-Stim® as a treatment modality with their patients, or who are interested in using it.

Discussion is invited regarding: 1) clinical cases (we ask that participants pay careful attention to issues of confidentiality) and the application of CES or MET, 2) research and treatment issues in various clinical settings, and 3) any other professional practice concerns or technical support issues. Marketing, sales, solicitation or other commercial advertising or similar uses are not allowed.

If you are interested in joining this online discussion group please email us. Please include your name, license type and provider number, and your address.

Interest in electrotherapy is growing

Medical Device Link has this article on neuromodulation:

http://www.devicelink.com/mddi/archive/07/07/002.html

It discusses some electrical therapies that are being used today and the great promise for the future with this approach. Too bad they don't mention Alpha-Stim, the most elegant!

Review article on CES and fibromyalgia

A new review article on cranial electrotherapy stimulation (CES) and fibromyalgia by Marshall Gilula, MD has just been published. This review appears in the current issue of the Expert Review of Medical Devices [Expert Rev. Med. Devices 4(4):489-495, 2007] and focuses on applications of CES in the management of common comorbidities of FM, as well as benefits of supplementation with D-ribose to increase energy levels and stress management with evoked potential biofeedback devices in patients with FM. Please contact us for a copy of the article and we will be happy to send it to you.

Article on CES in treatment of depression

A new review article has just been published in the June 2007 issue of Practical Pain Management on the use of cranial electrotherapy stimulation (CES) in the treatment of depression. This paper represents part 2 in a mini-series on the efficacy of CES in the treatment of depression and reviews the results of a meta-analysis conducted on CES studies. You may download a full-length version of this article here:

www.alleviahealth.com/PDF/Kirsch%20and%20Gilula%20(2007d2).pdf


Part 1 of this depression series reviewed diagnoses, treatment modalities and compared the efficacy of CES with that of SSRIs and SNRIs.

www.alleviahealth.com/PDF/Kirsch%20and%20Gilula%20(2007d1).pdf


Please note that similar succinct reviews of the efficacy and safety of cranial electrotherapy stimulation have been published on anxiety disorders,

www.alleviahealth.com/PDF/Kirsch%20and%20Gilula%20(2007a2).pdf

www.alleviahealth.com/PDF/Kirsch%20and%20Gilula%20(2007a1).pdf


treatment of headaches with microcurrent,

www.alleviahealth.com/PDF/Kirsch%20(2006_headaches).pdf


the treatment of pain in patients with fibromyalgia syndrome,

www.alleviahealth.com/PDF/Kirsch%20(2006_FM).pdf


. and a general tutorial on the use of microcurrent electrotherapy stimulation (MET) in the treatment of pain disorders is available for download here:

www.alleviahealth.com/PDF/Kirsch%20(2006_MET).pdf